Technical Analysis for AWH - Aspira Women's Health Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Bollinger Band Squeeze | Range Contraction | -5.40% | |
BB Squeeze + Lower Band Touch | Range Contraction | -5.40% | |
Below Lower BB | Weakness | -5.40% | |
Lower Bollinger Band Touch | Weakness | -5.40% | |
MACD Bearish Signal Line Cross | Bearish | -4.44% | |
Bollinger Band Squeeze | Range Contraction | -4.44% | |
BB Squeeze + Lower Band Touch | Range Contraction | -4.44% | |
Below Lower BB | Weakness | -4.44% | |
Lower Bollinger Band Touch | Weakness | -4.44% | |
Bollinger Band Squeeze | Range Contraction | -12.18% |
Alert | Time |
---|---|
10 DMA Resistance | 16 minutes ago |
Rose Above Previous Day's High | about 1 hour ago |
Rose Above Lower Bollinger Band | about 1 hour ago |
2x Volume Pace | about 1 hour ago |
1.5x Volume Pace | about 1 hour ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Aspira Women’s Health Inc. (formerly known as Vermillion, Inc. Nasdaq: VRML) is transforming women’s health with the discovery, development, and commercialization of innovative testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. OVA1®plus combines our FDA-cleared products OVA1® and OVERA® to detect the risk of ovarian malignancy in women with adnexal masses. ASPiRA GenetiXSM testing offers both targeted and a more comprehensive genetic testing options with a gynecologic focus. Our focus is on delivering products that allow healthcare providers to stratify risk, facilitate early detection, and optimize treatment.
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Clinical Medicine Oncology Healthcare Providers FDA Ovarian Cancer Genetic Testing Patient Management Analytical Solutions Gynaecological Cancer Gynaecology
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Clinical Medicine Oncology Healthcare Providers FDA Ovarian Cancer Genetic Testing Patient Management Analytical Solutions Gynaecological Cancer Gynaecology
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 6.75 |
52 Week Low | 2.3087 |
Average Volume | 23,553 |
200-Day Moving Average | 3.99 |
50-Day Moving Average | 3.40 |
20-Day Moving Average | 3.31 |
10-Day Moving Average | 3.19 |
Average True Range | 0.26 |
RSI (14) | 34.21 |
ADX | 24.18 |
+DI | 9.49 |
-DI | 25.66 |
Chandelier Exit (Long, 3 ATRs) | 2.84 |
Chandelier Exit (Short, 3 ATRs) | 3.30 |
Upper Bollinger Bands | 3.63 |
Lower Bollinger Band | 3.00 |
Percent B (%b) | -0.02 |
BandWidth | 19.15 |
MACD Line | -0.09 |
MACD Signal Line | -0.07 |
MACD Histogram | -0.0244 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 3.34 | ||||
Resistance 3 (R3) | 3.33 | 3.20 | 3.28 | ||
Resistance 2 (R2) | 3.20 | 3.10 | 3.20 | 3.26 | |
Resistance 1 (R1) | 3.09 | 3.05 | 3.14 | 3.10 | 3.24 |
Pivot Point | 2.95 | 2.95 | 2.98 | 2.96 | 2.95 |
Support 1 (S1) | 2.84 | 2.86 | 2.90 | 2.86 | 2.72 |
Support 2 (S2) | 2.71 | 2.80 | 2.72 | 2.70 | |
Support 3 (S3) | 2.60 | 2.71 | 2.68 | ||
Support 4 (S4) | 2.62 |